Mitochondrial complex III bypass complex I to induce ROS in GPR17 signaling activation in GBM

Area of Science:

• * Molecular Biology
• * Cellular Biology
• * Cancer Research

Background:

• * Glioblastoma multiforme (GBM) is a deadly brain tumor.
• * Guanine nucleotide binding protein (G protein) coupled receptor 17 (GPR17) is implicated in GBM cell signaling, reactive oxidative species (ROS) production, and cell death.
• * The precise mechanisms linking GPR17 to ROS levels and mitochondrial electron transport chain (ETC) complexes in GBM remain unclear.

Purpose of the Study:

• * To investigate the novel relationship between GPR17 and mitochondrial ETC complexes I and III in regulating intracellular ROS (ROSi) levels in GBM.
• * To elucidate the specific roles of ETC complexes I and III in GPR17-mediated ROS production in different GBM cell lines.
• * To identify potential therapeutic targets for GBM based on GPR17 and mitochondrial function.

Main Methods:

• * Utilized pharmacological inhibitors targeting ETC complexes I and III.
• * Employed GPR17 agonists and antagonists to modulate receptor activity.
• * Analyzed gene expression profiling, including RNA sequencing (RNAseq), in various GBM cell lines (1321N1, LN229, SNB19).
• * Quantified intracellular ROS levels under different treatment conditions.

Main Results:

• * GPR17 activation increased ROS levels, while its inhibition decreased ROS levels, in conjunction with ETC complex modulation.
• * ETC Complex III inhibition consistently increased ROS levels across GBM cell lines.
• * GPR17 activation led to the downregulation of NADH dehydrogenase genes (ETC I) and upregulation of cytochrome b and Ubiquinol Cytochrome c Reductase family genes (ETC III).
• * RNAseq analysis identified key genes involved in ROS and mitochondrial pathways, highlighting differences in ETC I function across GBM cell lines.

Conclusions:

• * Mitochondrial ETC Complex III bypasses ETC Complex I to elevate intracellular ROS in GPR17 signaling activation within GBM.
• * GPR17 signaling and its interplay with mitochondrial ETC complexes represent a promising avenue for novel GBM targeted therapies.
• * Understanding these mechanisms could lead to improved treatment strategies for glioblastoma.